PfeifferEF, ThumCh, ClemensAH. The artificial beta-cell. A continuous control of blood sugar by external regulation of insulin infusion (glucose-controlled-insulin-infusion-system). Horm Metab Res1974; 6: 339–42.
2.
PfeifferEF, ThumCh, ClemensAH. Die künstliche β-Zelle. Naturwissenschaften1974; 61: 455–6.
PfeifferEF, KernerW.Das künstliche Pankreas: Entwicklung und Bedeutung für die Erforschung und Behandlung der Zuckerkrankheit. Verh Dtsch Ges Inn Med1981; 87: 1408–28.
5.
KernerW, ThumCh, TamasGJr, BeischerW, ClemensAH, PfeifferEF. Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta cell. Horm Metab Res1976; 8 (Suppl): 256–61.
6.
KernerW, NavascuesI, TorresAA, PfeifferEF. Studies on the pathogenesis of the dawn phenomenon in insulin dependent diabetics. Metabolism1984; 33: 458–64.
7.
MatthiessenER, RubinP, ChristiansenJS, SvendsonPA, LauritzenT, DeckenT.Diurnal pattern of insulin requirements in insulin-dependent diabetics. Scand J Clin Lab Invest1982; 42: 63–8.
8.
KernerW, PfeifferEF. The artificial pancreas. In: EllisSamols, ed. The endocrine pancreas.New York: Raven Press Ltd., 1991; 441–56.
9.
AriasP, KernerW, ZierH, NavascuesI, PfeifferEF. Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and means of semiambulatory 24-hour continuous blood glucose monitoring. Diabetes Care1985; 8: 134–40.
10.
KernerW, BeischerW, MaierV, PfeifferEF. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin dependent diabetics. Horm Metab Res1979; 8 (Suppl): 71–80.
11.
CroffordOB. DCCT update. 74th Annual Meeting, The Endocrine Society1992.
12.
ZierH, KernerW, SteinbachG, PfeifferEF. Mobile und transportable Blutglucosemonitoren: Methodische und technische Aspekte. Verh Dtsch Ges Inn Medizin1987; 93: 312–15.
13.
BrückelJ, ZierH, KernerW, PfeifferEF. Progress in practical endocrinology: The Glucosensor Unitec Ulm - a portable monitor for continuous blood glucose measurement. Horm Metab Res1990; 22: 382–4.
14.
PfeifferEF. Continuous glucose monitoring by potable glucose sensors unmasks hyperglycemic excursions not reflected by elevated HbA1 and fructosamine values - the missing link in the DCCT (Diabetes Control and Complication Trial)?Paper given to the Diabetes-Symposium “Advanced glycosylation end-products in diabetic micro and macrovasculopathy”, Boston.1992; 8–11.
15.
Eller. Diss. Ulm1993 (in press).
16.
KernerW, ZierH, SteinbackG, A potentially implantable enzyme electrode for amperometric measurement of glucose. Horm Metab Res1988; 20: 8–13.
17.
BrückelJ, KernerW, ZierH, SteinbachG, PfeifferEF. In vivo measurement of subcutaneous glucose concentrations with an enzymatic glucose sensor and a wick method. Klin Wochenschr1989; 67: 491–5.
18.
FischerU.Fundamentals of glucose sensors. Diabetic Medicine1991: 8: 309–21.
19.
DoldererM, De la FuenteA, KernerW, ZierH, SteinbachG, PfeifferEF. Mobile und transportable Blutglukosemonitoren: Bedeutung für Diagnose und Therapie des Diabetes mellitus. Verh Dtsch Ges Inn Med1987; 93: 312–5.
20.
KernerW, KeckFS, ZierH, PfeifferEF. Hydrogen peroxide detecting enzyme glucose sensors are impaired by human material; paper presented to the 1. Nizza: Conference on Biomedical Engineering, 1991; 2: 17–20.
21.
BitoL, DavsonH, LevinE, MurrayM, SniderN.The concentrations of free amino acids and other electrolytes in plasma in the dog. J Neurochem1966; 13: 1057–67.
22.
DelgadoJMR, DeFeudisFV, RothRH, RyugoDK, MitrukaBK. Dialytrode for long term intracerebral perfusion in awake monkeys. Arch Int Pharmacodyn1972; 198: 9–21.
TellezS, ForgesNF, RoussinA.Coupling of microdialysis with capillary electrophoresis: a new approach to the study of drug transfer between two compartments of the body in freely moving rats. J Chromatogr1992; 581: 257–66.
25.
JanssonPA, FowelinJ, SmithU, LönnrothP.Characterization by microdialysis of subcutaneous glucose level in subcutaneous tissue in humans. Am J Physiol1988; 225: E128–20.
26.
BolinderJ, HagströmE, UngerstedtU, ArnerP.Microdialysis of subcutaneous adipose tissue in vivo for continuous glucose monitoring in man. Scand J Clin Lab Invest1989; 49: 465–74.
27.
KeckFS, KernerW, MeyerhoffC, ZierH, PfeifferEF. Combination of microdialysis and glucosensor permits continuous (on line) s.c. glucose monotoring in a patient operated device: I - In vitro evaluation. Horm Metab Res1991; 23: 617–8.
28.
KeckFS, MeyerhoffC, KernerW, SiegmundT, ZierH, PfeifferEF. Combination of microdialysis and glucosensor permits continuous (on line) s.c. glucose monitoring in a patient operated device: II - Evaluation in animals. Horm Metab Res1992; 24: 492–3.
29.
SternbergF, MeyerhoffC, MennelFJ, ZierH, BischofF, PfeifferEF. Independent method to estimate the glucose concentration in the subcutaneous tissue. Recovery in vivo. Horm Metab Res1993; 25: 68 (A).
30.
MeyerhoffC, BischofF, SternbergF, ZierH, PfeifferEF. On line continous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis. Diabetologia1993; 35: 1087–92.
31.
PfeifferEF, MeyerhoffC, BischofF, KeckFS, KernerW.On line continous monitoring of subcutaneous tissue glucose is feasible by combining portable glucosensor with microdialysis. Horm Metab Res1993; 25: 121–4.